Hepatitis E : latest developments in knowledge

Simple item page
dc.centroUniversidad Cardenal Herrera-CEU
dc.contributor.authorSuay García, Beatriz
dc.contributor.authorGarcía Andrés, Marioes
dc.contributor.authorMateos Lindemann, María Luisaes
dc.contributor.authorPérez Gracia, María Teresa
dc.contributor.otherUCH. Departamento de Farmacia
dc.contributor.otherUCH. Departamento de Matemáticas, Física y Ciencias Tecnológicas
dc.contributor.otherProducción Científica UCH 2016
dc.date2016es
dc.date.accessioned2019-02-21T05:00:31Z
dc.date.available2019-02-21T05:00:31Z
dc.date.issued2016-05-21
dc.descriptionEste artículo se encuentra disponible en la siguiente URL: https://www.futuremedicine.com/doi/10.2217/fmb-2016-0012es
dc.descriptionEste es el post-print del siguiente artículo, Pérez Gracia, MT., Suay García, B., García Andrés, M. & Mateos Lindemann, ML. (2016). Hepatitis E : latest developments in knowledge. Future Microbiology, vol 11, n. 6, que se ha publicado de forma definitiva en https://doi.org/10.2217/fmb-2016-0012
dc.descriptionThis is the peer reviewed version of the following article: Pérez Gracia, MT., Suay García, B., García Andrés, M. & Mateos Lindemann, ML. (2016). Hepatitis E : latest developments in knowledge. Future Microbiology, vol 11, n. 6, which has been published in final form at https://doi.org/10.2217/fmb-2016-0012
dc.description.abstractHepatitis E, caused by Hepatitis E virus (HEV), is a highly prevalent disease in developing countries. In developed nations, autochthonous HEV infections seem to be an emergent disease. Its clinical manifestations and epidemiology are well known for endemic countries. It has been confirmed that hepatitis E is a zoonosis and that parenteral transmission can also occur. The molecular mechanisms of HEV replication are not fully understood, mostly because there are no efficient cell culture systems. HEV can cause chronic hepatitis in organ transplant recipients and immunocompetent patients. Cases with fulminant hepatitis and other extrahepatic manifestations have also been reported. The diagnosis is based on serological studies and detection of HEV RNA in blood and feces. Treatment with ribavirin and/or pegylated-IFN-α have proven to be successful in some cases. The recently approved/marketed vaccine is a good option in order to prevent this infection.
dc.formatapplication/pdfes
dc.identifier.citationPérez Gracia, MT., Suay García, B., García Andrés, M. & Mateos Lindemann, ML. (2016). Hepatitis E : latest developments in knowledge. Future Microbiology, vol 11, n. 6. DOI: https://doi.org/10.2217/fmb-2016-0012
dc.identifier.doihttps://doi.org/10.2217/fmb-2016-0012
dc.identifier.issn1746-0913.
dc.identifier.issn1746-0921.
dc.identifier.urihttp://hdl.handle.net/10637/10001
dc.language.isoenes
dc.publisherFuture Science Group.
dc.relationEste artículo está financiado a través de varias becas de la Universidad CEU Cardenal Herrera (PRUCH 25/10, PRUCH 39/11 and Santander-PRUCH 19/12; INDI1420).
dc.relationUCH. Financiación Universidad.
dc.relation.ispartofFuture Microbiology, vol 11 (may 2016), n. 6.
dc.relation.projectIDPRUCH 25/10
dc.relation.projectIDPRUCH 39/11
dc.relation.projectIDSantander-PRUCH 19/12
dc.relation.projectIDINDI14/20
dc.rights.cchttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subjectVirus de la Hepatitis E - Vacunación.es
dc.subjectHepatitis E - Tratamiento.es
dc.subjectHepatitis E - Treatment.es
dc.subjectHepatitis E - Vacunación.es
dc.subjectVacunas.es
dc.subjectHepatitis E virus - Treatment.es
dc.subjectHígado - Enfermedades - Tratamiento.es
dc.subjectLiver - Diseases - Treatment.es
dc.subjectVirus de la Hepatitis E - Tratamiento.es
dc.subjectHepatitis E virus - Vaccination.es
dc.subjectHepatitis E - Vaccination.es
dc.subjectVaccines.es
dc.titleHepatitis E : latest developments in knowledgees
dc.typeArtículoes
dspace.entity.typePublicationes
europeana.dataProviderUNIVERSIDAD SAN PABLO CEU
europeana.isShownAthttp://hdl.handle.net/10637/10001
europeana.objecthttp://repositorioinstitucional.ceu.es/visor/libros/707432/thumb_europeana/707432.jpg
europeana.providerHispana
europeana.rightshttp://creativecommons.org/publicdomain/zero/1.0/
europeana.typeTEXT
relation.isAuthorOfPublication809b61ac-ad5a-4bd9-b37d-e6d407e5112f
relation.isAuthorOfPublicationc5ba1a0b-071c-432a-9cfd-ffddb88d96a0
relation.isAuthorOfPublication.latestForDiscovery809b61ac-ad5a-4bd9-b37d-e6d407e5112f

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Hepatitis_Perez_FM_2016.pdf
Size:
3.5 MB
Format:
Adobe Portable Document Format
Download

Collections

Dpto. Farmacia
x

The user has the obligation to use the services and content provided by the University, in particular, printed and electronic resources, in accordance with current legislation and the principles of good faith and generally accepted uses, without contravening with its performance the public order, especially, in the case in which, for the adequate performance of its activity, it needs to reproduce, distribute, communicate and/or make available, fragments of printed works or capable of being in analog or digital format, either on paper or electronic support. Law 23/2006, of July 7, which modifies the revised text of the Intellectual Property Law, approved by Royal Legislative Decree 1/1996, of April 12. B.O.E. n 162, of July 8, and concordant regulations.

@ 2024 Fundación Universitaria San Pablo CEU (Madrid). All rights reserved.

DSpace Software Copyright © 2002-2013 Duraspace